Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics #00317

Submission Number:
00317
Commenter:
emad mousad
State:
California
Initiative Name:
Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
im a pharmacist at express pharmacy Hanford Ca i have been practicing pharmacy since 2001. and its crystal clear to me that PBMs are compromising that practice by forcing the use of contractual "gag clauses" that require my silence when I see a less expensive, but equally effective alternative to a prescribed drug (usually a generic) "Although drug prices are skyrocketing, non-PBM-owned pharmacies are being reimbursed drastically below cost. Meanwhile, PBMs force patients to use PBM-owned mail order and PBM-owned retail pharmacies (like CVS) in order to save on their copays. This is anticompetitive behavior that downgrades pharmacy and the seriousness of prescription medical treatment, as if buying prescription drugs were the same as buying dish soap or paper towels ..."